1 employees
Nivien Therapeutics is developing the first small molecule drugs to enhance both chemo and immunotherapies.
2016
$600K
from 2 investors over 2 rounds
Nivien Therapeutics raised $600K on December 1, 2017
Investors: IndieBio and SOSV - The Accelerator VC